A deep dive into antibody-drug conjugates with Daiichi Sankyo's Ken Keller
Ken Keller describes recent advances in ADC technology, talks about the recent Merck deal, and what it was like to change breast cancer at ASCO in 2022.
![](https://static.wixstatic.com/media/08e71b_af721c3fbee940a6bf6e6728196fdcac~mv2.jpeg/v1/fill/w_144,h_54,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/08e71b_af721c3fbee940a6bf6e6728196fdcac~mv2.jpeg)
Also look for unique social pages for BiotechTV U.
Breakthrough Properties is a life science real estate company that is exclusively focused on delivering cutting-edge environments for the life science industry. With a portfolio of roughly 5 million square feet across the US, UK and continental Europe, Breakthrough has emerged as a leading partner for high-growth biotechs and pharmas around the world.